New UC Guidelines Preferentially Rank Biologics New UC Guidelines Preferentially Rank Biologics
New guidance for moderate to severe UC prioritizes early use of biologics after 5-ASA failure and preferentially ranks infliximab and golimumab as first-line options in biologic-na ï ve patients.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news
More News: Gastroenterology | Remicade